365
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Targeting bacterial growth in biofilm conditions: rational design of novel inhibitors to mitigate clinical and food contamination using QSAR

, , , , , , & ORCID Icon show all
Article: 2330907 | Received 25 Oct 2023, Accepted 06 Mar 2024, Published online: 23 Apr 2024

References

  • Mah TF, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9(1):1–19.
  • Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857–2876.
  • Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603.
  • Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, RolstonKV, Sader HS, Jones RN. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance pro. Antimicrob Agents Chemother. 2019;63(7):e00355-19.
  • Wyres KL, Hold KG. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr Opin Microbiol. 2018;45:131–139.
  • Souza-Guerra ME, Destro G, Vieira B, Lima AS, Caldas-Ferraz LF, Hakansson AP, Darrieux M, Rojas-Converso T. Klebsiella pneumoniae biofilms and their role in disease pathogenesis. Front Cell Infect Microbiol. 2022;12:877995.
  • Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol. 2016;322:207–228.
  • Chipolombwe J, Török ME, Mbelle N, Nyasulu P. Methicillin-resistant Staphylococcus aureus multiple sites surveillance: a systemic review of the literature. Infect Drug Resist. 2016;9:35–42.
  • Vadyvaloo V, Otto M. Molecular genetics of Staphylococcus epidermidis biofilms on indwelling medical devices. Int J Artif Organs. 2005;28(11):1069–1078.
  • Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev. 2010;23(2):382–398.
  • Antequera-Gómez ML, Díaz-Martínez L, Guadix JA, Sánchez-Tévar AM, Sopeña-Torres S, Hierrezuelo J, Doan HK, Leveau JHJ, De Vicente A, Romero D. Sporulation is dispensable for the vegetable-associated life cycle of the human pathogen Bacillus cereus. Microb Biotechnol. 2021;14(4):1550–1565.
  • Mirzaei R, Mohammadzadeh R, Alikhani MY, Moghadam MS, Karampoor S, Kazemi S, Barfipoursalar A, Yousefimashouf R. The Biofilm-associated bacterial infections unrelated to indwelling devices. Iubmb Life . 2020;72(7):1271–1285.
  • Romero D, Aguilar C, Losick R, Kolter R. Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proc Natl Acad Sci USA. 2010;107(5):2230–2234.
  • Romero D, Vlamakis H, Losick R, Kolter R. Funtional analysis of the accesory protein TapA in Bacillus subtilis amyloid fiber assembly. J Bacteriol. 2014;196(8):1505–1513.
  • Romero D, Kolter R. Functional amyloids in bacteria. Res Rev. 2014;17:65–73.
  • Gram L, Ravn L, Rasch M, Bruhn JB, Christensen AB, Givskov M. Food spoilage-interactions between food spoilage bacteria. Int J Food Microbiol. 2002;78(1–2):79–97.
  • Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P, Spitzer M, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463–477.
  • Macalino SJ, Gosu V, Hong S, Choi S. Role of computer-aided drug design in modern drug discovery. Arch Pharm Res. 2015;38(9):1686–1701.
  • Lin X, Li X, Lin X. A review on applications of computational methods in drug screening and design. Molecules. 2020;25(6):1375.
  • Shaker B, Ahmad S, Lee J, Jung C, Na D. In silico methods and tools for drug discovery. Comput Biol Med. 2021;137:104851.
  • Bruno A, Costantino G, Sartori L, Radi M. The in silico drug discovery toolbox: applications in lead discovery and optimization. Curr Med Chem. 2019;26(21):3838–3873.
  • Zagotto G, Bortoli M. Drug design: where we are and future prospects. Molecules. 2021;26(22):7061.
  • Dean PM, Lloyd DG, Todorov NP. De novo drug design: integration of structure-based and ligand-based methods. Curr Opin Drug Discov Devel. 2004;7(3):347–353.
  • Bueso-Bordils JI, Alemán-López PA, Suay-García B, Martín-Algarra R, Duart MJ, Falcó A, Antón-Fos GM. Molecular topology for the discovery of new broad-spectrum antibacterial drugs. Biomolecules. 2020;10(9):1343.
  • Bueso-Bordils JI, Alemán-López PA, Martín-Algarra R, Duart MJ, Falcó A, Antón-Fos GM. Molecular topology for the search of new anti-MRSA compounds. Int J Mol Sci. 2021;22(11):5823.
  • Zanni R, Galvez-Llompart M, Machuca J, Garcia-Domenech R, Recacha E, Pascual A, Rodriguez-Martinez JM, Galvez J. Molecular topology: a new strategy for antimicrobial resistance control. Eur J Med Chem. 2017;137:233–246.
  • Zanni R, Martínez-Cruz J, Gálvez-Llompart M, Fernández-Ortuño D, Romero D, García-Domènech R, Pérez-García A, Gálvez J. Rational design of chitin deacetylase inhibitors for sustainable agricultural use based on molecular topology. J Agric Food Chem. 2022;70(41):13118–13131.
  • Zanni R, Galvez-Llompart M, Garcia-Domenech R, Galvez J. What place does molecular topology have in today’s drug discovery? Expert Opin Drug Discov. 2020;15(10):1133–1144.
  • Blay V, García-Domenech R, Gálvez J. Problem solving with Molecular Topology: a walkthrough. ChemTexts. 2017;3(2):1–5.
  • Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49:1388–D1395.
  • (a) Mills N. ChemDraw Ultra 10.0. CambridgeSoft, 100 Cambridge Park Drive, Cambridge, MA 02140. www.cambridgesoft.com. J Am Chem Soc. 2006;128:13649–13650.(b) Cousins K. ChemDraw Ultra 9.0. CambridgeSoft, 100 Cambridge Park Drive, Cambridge, MA 02140. www.cambridgesoft.com. J Am Chem Soc. 2005;127:4115–4116.
  • Mauri A. alvaDesc: a tool to calculate and analyze molecular descriptors and fingerprints. In: Roy K, editor. Ecotoxicological QSARs. New York (NY): Humana; 2020. Chapter, Methods in pharmacology and toxicology; p. 801–820.
  • Solberg HE. Discriminant analysis. CRC Crit Rev Clin Lab Sci. 1978;9(3):209–242.
  • StatSoft I. 2001 STATISTICA (data analysis software system), version 6. Vol. 150. Tulsa (OK): StatSoft, 734 Inc.; p. 91–94.
  • Gálvez J, García-Domenech R, de Gregorio Alapont C, de Julián-Ortiz JV, Popa L. Pharmacological distribution diagrams: a tool for de novo drug design. J Mol Graph. 1996;14(5):272–276.
  • Flemming HC, Wuertz S. Bacteria and archaea on Earth and their abundance in biofilms. Nat Rev Microbiol. 2019;17(4):247–260.
  • Qvortrup K, Hultqvist LD, Nilsson M, Jakobsen TH, Jansen CU, Uhd J, Andersen JB, Nielsen TE, Givskov M, Tolker-Nielsen T. Small molecule anti-biofilm agents developed on the basis of mechanistic understanding of biofilm formation. Front Chem. 2019;7:742.
  • Geesi MH. Synthesis, antibacterial evaluation, Crystal Structure and Hirshfeld surface analysis of a new 2-Benzylsulfanyl-3-(4-fluoro-phenyl)-6-methyl-3H-quinazolin-4-one. J Mol Struct. 2020;1208:127894.
  • Khazi IM, Koti RS, Chadha MV, Mahajanshetti CS, Gadad AK. Synthesis and evaluation of the antibacterial and antitubercular activity of some N1-aral-N4-(3-chloro-4-fluorophenyl) thiosemicarbazones and their copper(I) complexes. Arzneimittelforschung. 2005;55(2):107–113.
  • Romero D, Sanabria-Valentín E, Vlamakis H, Kolter R. Biofilm inhibitors that target amyloid proteins. Chem Biol. 2020;20(1):102–110.
  • Majik MS, Gawas UB, Mandrekar VK. Next generation quorum sensing inhibitors: accounts on structure activity relationship studies and biological activities. Bioorg Med Chem. 2020;28(21):115728.
  • Petri GL, Spanò V, Spatola R, Holl R, Raimondi MV, Barraja P, Montalbano A. Bioactive pyrrole-based compounds with target selectivity. Eur J Med Chem. 2020;208:112783.
  • Sardessai Y, Bhosle S. Tolerance of bacteria to organic solvents. Res Microbiol. 2002;153(5):263–268.
  • Shinde S, Lee LH, Chu T. Inhibition of biofilm formation by the synergistic action of EGCG-S and antibiotics. Antibiotics. 2021;10(2):102.
  • Stenvang M, Dueholm MS, Vad BS, Seviour T, Zeng G, Geifman-Shochat S, Søndergaard MT, Christiansen G, Meyer RL, Kjelleberg S, et al. Epigallocatechin gallate remodels overexpressed functional amyloids in Pseudomonas aeruginosa and increases biofilm susceptibility to antibiotic treatment. J Biol Chem. 2016;291(51):26540–26553.
  • Spengler G, Kincses A, Mosolygó T, Marć MA, Nové M, Gajdács M, Sanmartín C, McNeil HE, Blair JMA, Domínguez-Álvarez E. Antiviral, antimicrobial and antibiofilm activity of selenoesters and selenoanhydrides. Molecules. 2019;24(23):4264–4280.
  • Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, Yin M, Zeng X, Wu C, Lu A, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021;49(W1):W5–W14.